Quarterly Results

  • Company Name :
Glaxosmithkline Pharmaceuticals Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 500660
  • NSE Symbol:
  • GLAXO
  • P/E(TTM):
  • 64.56
  • ISIN Demat:
  • INE159A01016
  • Div & Yield%:
  • 1.64
  • EPS(TTM):
  • 51.09
  • Book Value(₹):
  • 115.06
  • Market Cap(₹Cr.):
  • 55,875.19
  • Face Value(₹):
  • 10.00
Quarters :  
Particulars March 2025 ( Cr)December 2024 ( Cr)September 2024 ( Cr)
Gross Sales 966.08 946.36 1,000.05
Excise Duty 0.00 0.00 0.00
Net Sales 966.08 946.36 1,000.05
Other Operating Income 0.00 0.00 0.00
Other Income 39.46 35.06 36.88
Total Income 1,005.54 981.42 1,036.93
Total Expenditure 635.34 656.18 681.10
PBIDT 370.20 325.24 355.83
Interest 0.58 0.09 0.27
PBDT 369.62 325.15 355.56
Depreciation 14.72 18.80 16.86
Tax 89.34 73.05 97.46
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 5.42 4.72 -7.45
Reported Profit After Tax 260.14 228.58 248.69
Extra-ordinary Items 0.00 0.00 3.34
Adjusted Profit After Extra-ordinary item 260.14 228.58 245.35
EPS (Unit Curr.) 15.35 13.49 14.45
EPS (Adj) (Unit Curr.) 15.35 13.49 14.45
Calculated EPS (Unit Curr.) 15.36 13.49 14.68
Calculated EPS (Adj) (Unit Curr.) 15.36 13.49 14.68
Calculated EPS (Ann.) (Unit Curr.) 61.42 53.97 58.72
Calculated EPS (Adj) (Ann.) (Unit Curr.) 61.42 53.97 58.72
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 240.00 120.00
Equity 169.41 169.41 169.41
Reserve & Surplus 0.00 0.00 0.00
Face Value 10.00 10.00 10.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 38.32 34.37 35.58
PBDTM(%) 38.26 34.36 35.55
PATM(%) 26.93 24.15 24.87